nach oben

Sleep and Breathing

Erschienen in:

06.05.2023 | Sleep Breathing Physiology and Disorders • Original Article

Cardiovascular remodeling in active and controlled acromegaly: association with sleep-disordered breathing

verfasst von: Irina Filchenko, Lyudmila Korostovtseva, Mikhail Bochkarev, Uliana Tsoy, Yuri Sviryaev

Erschienen in: Sleep and Breathing | Ausgabe 6/2023

Einloggen, um Zugang zu erhalten

Abstract

Purpose

We hypothesized that an unfavorable cardiovascular profile in acromegaly is associated with sleep-disordered breathing (SDB), while acromegaly control improves both respiratory sleep characteristics and the cardiovascular profile.

Methods

The patients underwent the assessment of breathing during sleep and cardiovascular profile assessment at the start of the study including arterial stiffness, blood pressure, echocardiography, nocturnal heart rate variability (HRV). The assessment was repeated in patients with acromegaly at 1 year after transsphenoidal adenectomy (TSA).

Results

A total of 47 patients with acromegaly and 55 control subjects were enrolled. At one year after TSA, 22 patients with acromegaly were reassessed. Multiple linear regression analysis with adjustment for age, sex and body mass index (BMI) showed the associations of insulin growth-like factor 1 (IGF-1) with obstructive apnea index (OAI: β=0.035/h, p<0.001), but not with cardiovascular parameters, in patients with acromegaly. The analysis of combined acromegaly and control dataset with adjustment for age, sex and BMI showed the association the presence of acromegaly with diastolic blood pressure (DBP; β=17.99 mmHg, p<0.001), ejection fraction (EF; β=6.23%, p=0.009), left heart remodeling (left ventricle posterior wall: β=0.81 mm, p=0.045) and the association of the presence of SDB (apnea-hypopnea index≥15/h) with left ventricular function (EF: -4.12%, p=0.040; end systolic volume: 10.12 ml, p=0.004). Control of acromegaly was accompanied by the decrease in OAI (5.9 [0.8, 14.5]/h and 1.7 [0.2, 5.1]/h, p=0.004) and nocturnal heart rate (66.1 [59.2, 69.8] bpm and 61.7 [54.0, 67.2] bpm, p=0.025) and by the increase in blood pressure (DBP: 78.0 [70.3, 86.0] mm Hg and 80.0 [80.0, 90.0] mm Hg, p=0.012).

Conclusion

The comorbidities of acromegaly, including sleep-disordered breathing, appear to have a long-term effect on cardiovascular remodeling in active acromegaly. Future studies should investigate the applicability of the treatment of SDB for the reduction of cardiovascular risk in acromegaly.

Nur mit Berechtigung zugänglich

Colao A, Grasso LFS, Giustina A, Melmed S, Chanson P, Pereira AM et al (2019) Acromegaly. Nat Rev Dis Primers 5:1–17. https://doi.org/10.1038/s41572-019-0071-6CrossRef

Kashine S, Kishida K, Funahashi T, Shimomura I (2012) Characteristics of sleep-disordered breathing in Japanese patients with acromegaly. Endocr J 59:31–38. https://doi.org/10.1507/endocrj.ej11-0171

Castellani C, Francia G, Dalle Carbonare L, Ferrari M, Viva E, Cerini R et al (2016) Morphological study of upper airways and long-term follow-up of obstructive sleep apnea syndrome in acromegalic patients. Endocrine 51:308–316. https://doi.org/10.1007/s12020-015-0659-x

Sanchez-Ortiga R, Climent V, Sanchez-Tejada L, Candela A, Pico A (2015) Severe sleep apnea-hypopnea syndrome is related to left ventricle dysfunction and hypertrophy in acromegalic patients. Endocrinol Nutr 62:366–372. https://doi.org/10.1016/j.endonu.2015.05.007CrossRefPubMed

Benjafield AV, Ayas NT, Eastwood PR, Heinzer R, Ip MSM, Morrell MJ et al (2019) Estimation of the global prevalence and burden of obstructive sleep apnoea: a literature-based analysis. Lancet Respir Med 7:687–698. https://doi.org/10.1016/S2213-2600(19)30198-5CrossRefPubMedPubMedCentral

Montandon G, Liu H, Horner RL (2016) Contribution of the respiratory network to rhythm and motor output revealed by modulation of GIRK channels, somatostatin and neurokinin-1 receptors. Sci Rep 6:1–15. https://doi.org/10.1038/srep32707CrossRef

Parolin M, Dassie F, Alessio L, Wennberg A, Rossato M, Vettor R et al (2020) Obstructive Sleep Apnea in Acromegaly and the Effect of Treatment: A Systematic Review and Meta-Analysis. J Clin Endocrinol Metab:105. https://doi.org/10.1210/clinem/dgz116

Davi MV, Dalle Carbonare L, Giustina A, Ferrari M, Frigo A, Lo Cascio V et al (2008) Sleep apnoea syndrome is highly prevalent in acromegaly and only partially reversible after biochemical control of the disease. Eur J Endocrinol 159:533–540. https://doi.org/10.1530/EJE-08-0442CrossRefPubMed

Yoshihisa A, Takeishi Y (2019) Sleep disordered breathing and cardiovascular diseases. J Atheroscler Thromb 26:315–327. https://doi.org/10.5551/jat.RV17032CrossRefPubMedPubMedCentral

10.

Ritvonen E, Löyttyniemi E, Jaatinen P, Ebeling T, Moilanen L, Nuutila P et al (2016) Mortality in acromegaly: A 20-year follow-up study. Endocr Relat Cancer 23:469–480. https://doi.org/10.1530/ERC-16-0106CrossRefPubMed

11.

Cao W, Wang X, Luo J, Huang R, Xiao Y (2021) Impact of obstructive sleep apnea on cardiovascular risk in patients with acromegaly. Sleep Med 80:193–198. https://doi.org/10.1016/j.sleep.2021.01.033CrossRefPubMed

12.

Wolters TLC, Roerink SHPP, Drenthen LCA, van Haren-Willems JHGM, Wagenmakers MAEM, Smit JWA et al (2020) The course of obstructive sleep apnea syndrome in patients with acromegaly during treatment. J Clin Endocrinol Metab 105:290–304. https://doi.org/10.1210/clinem/dgz050CrossRefPubMed

13.

Katznelson L, Laws ER, Melmed S, Molitch ME, Murad MH, Utz A et al (2014) Acromegaly: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 99:3933–3951. https://doi.org/10.1210/jc.2014-2700CrossRefPubMed

14.

Chuang CC, Lin SY, Pai PC, Yan JL, Toh CH, Lee ST et al (2017) Different volumetric measurement methods for pituitary adenomas and their crucial clinical significance. Sci Rep 7:1–12. https://doi.org/10.1038/srep40792CrossRef

15.

Williams B, Mancia G, Spiering W, Rosei EA, Azizi M, Burnier M et al (2018) 2018 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 39:3021–3104. https://doi.org/10.1097/HJH.0b013e3281fc975aCrossRef

16.

Vollmer M (2019) HRVTool - an Open-Source Matlab Toolbox for Analyzing Heart Rate Variability. Comput Cardiol Conf 2019 45:3–6. https://doi.org/10.22489/cinc.2019.032CrossRef

17.

Tobaldini E, Proserpio P, Oppo V, Figorilli M, Fiorelli EM, Manconi M et al (2019) Cardiac autonomic dynamics during sleep are lost in patients with TIA and stroke. J Sleep Res:1–9. https://doi.org/10.1111/jsr.12878

18.

Tsoy UA, Korostovtseva LS, Sviryaev YV, Semenov AP, Vaulina DA, Kravchenko SO et al (2014) Prevalence of sleep-disordered breathing in patients with newly diagnosed acromegaly. Ann Clin Med, pp. 36–42. https://doi.org/10.18786/2072-0505-2014-32-36-42

19.

Roemmler J, Gutt B, Fischer R, Vay S, Wiesmeth A, Bidlingmaier M et al (2012) Elevated incidence of sleep apnoea in acromegaly - Correlation to disease activity. Sleep Breath 16:1247–1253. https://doi.org/10.1007/s11325-011-0641-7CrossRefPubMed

20.

Vouzouneraki K, Franklin KA, Forsgren M, Wärn M, Tiberg J, Wik H et al (2018) Temporal relationship of sleep apnea and acromegaly : a nationwide study. Endocrine:456–463. https://doi.org/10.1007/s12020-018-1694-1

21.

Popielarz-Grygalewicz A, Gasior JS, Konwicka A, Grygalewicz P, Stelmachowska-Banaś M, Zgliczyński W et al (2018) Heart in Acromegaly: The Echocardiographic Characteristics of Patients Diagnosed with Acromegaly in Various Stages of the Disease. Int. J Endocrinol. https://doi.org/10.1155/2018/6935054

22.

Kormányos Á, Domsik P, Kalapos A, Gyenes N, Valkusz Z, Lengyel C et al (2020) Active acromegaly is associated with enhanced left ventricular contractility: Results from the three-dimensional speckle-tracking echocardiographic MAGYAR-Path Study. Rev Port Cardiol 39:189–196. https://doi.org/10.1016/j.repc.2019.08.010CrossRefPubMed

23.

Kormányos Á, Domsik P, Kalapos A, Valkusz Z, Lengyel C, Forster T et al (2018) Three-dimensional speckle tracking echocardiography–derived left atrial deformation analysis in acromegaly (Results from the MAGYAR-Path Study). Echocardiography 35:975–984. https://doi.org/10.1111/echo.13860CrossRefPubMed

24.

Filchenko I, Korostovtseva L, Bochkarev M, Boyarinova M, Alieva A, Rotar O et al (2021) Pulse wave velocity is decreased in acromegaly compared to non-acromegaly study participants with similar cardiovascular risk profile. Growth Hormon IGF Res 57–58:101395. https://doi.org/10.1016/j.ghir.2021.101395CrossRef

25.

Doonan RJ, Scheffler P, Lalli M, Kimoff RJ, Petridou ETH, Daskalopoulos ME et al (2011) Increased arterial stiffness in obstructive sleep apnea: a systematic review. Hypertens Res 34:23–32. https://doi.org/10.1038/hr.2010.200CrossRefPubMed

26.

Bradicich M, Sievi NA, Grewe FA, Gasperetti A, Kohler M, Schwarz EI (2020) Nocturnal heart rate variability in obstructive sleep apnoea: A cross-sectional analysis of the Sleep Heart Health Study. J Thorac Dis 12:S129–S138. https://doi.org/10.21037/jtd-cus-2020-005CrossRefPubMedPubMedCentral

27.

Kapa S, Kuniyoshi FHS, Somers VK (2008) Sleep apnea and hypertension: Interactions and implications for management. Hypertension 51:605–608. https://doi.org/10.1161/HYPERTENSIONAHA.106.076190CrossRefPubMed

28.

Buchhorn R, Willaschek C (2020) Growth Hormone Treatment, Cardiovascular Risk and Autonomic Maturation in Children and Adolescents with Growth Hormone Deficiency or Born Small for Gestational Age. Open J Pediatr 10:12–29. https://doi.org/10.4236/ojped.2020.101002CrossRef

29.

Ohshima H, Adachi H, Enomoto M, Fukami A, Nakamura S, Nohara Y et al (2020) Association between growth hormone and hypertension in a general population. Hypertens Res 43:1430–1436. https://doi.org/10.1038/s41440-020-0500-7CrossRefPubMed

30.

Gómez-Barrado JJ, Turégano S, Marcos G, Porras Y (2007) Dilated cardiomyopathy in a patient with acromegaly: echocardiographic development after treatment. Rev Esp Cardiol 60:213–214. https://doi.org/10.1016/S0300-8932(07)75015-7

31.

Guo X, Cao Y, Cao J, Li X, Liu P, Wang Z et al (2020) Reversibility of Cardiac Involvement in Acromegaly Patients After Surgery: 12-Month Follow-up Using Cardiovascular Magnetic Resonance. Front Endocrinol (Lausanne) 11:1–11. https://doi.org/10.3389/fendo.2020.598948CrossRef

32.

Minniti G, Moroni C, Jaffrain-Rea ML, Esposito V, Santoro A, Affricano C et al (2001) Marked improvement in cardiovascular function after successful transsphenoidal surgery in acromegalic patients. Clin Endocrinol 55:307–313. https://doi.org/10.1046/j.1365-2265.2001.01343.xCrossRef

Titel: Cardiovascular remodeling in active and controlled acromegaly: association with sleep-disordered breathing
verfasst von: Irina Filchenko
Lyudmila Korostovtseva
Mikhail Bochkarev
Uliana Tsoy
Yuri Sviryaev
Publikationsdatum: 06.05.2023
Verlag: Springer International Publishing
Erschienen in: Sleep and Breathing / Ausgabe 6/2023
Print ISSN: 1520-9512
Elektronische ISSN: 1522-1709
DOI: https://doi.org/10.1007/s11325-023-02838-9

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Cardiovascular remodeling in active and controlled acromegaly: association with sleep-disordered breathing